FDA/CDC

FDA queries more companies about youth e-cig use


 

Four more e-cigarette manufacturers are facing Food and Drug Administration scrutiny in an effort for the agency to better understand youth appeal and usage of e-cigarettes.

“Too many kids continue to experiment with e-cigarette and vaping products, putting them at risk for developing a lifelong nicotine addiction,” FDA Commissioner Scott Gottlieb, MD, said in a statement. “These products should never be marketed to, sold to, or used by kids, and it’s critical that we take aggressive steps to address the youth use of these products.”

ecigarette teenager Thinkstockphotos.com
The agency sent letters May 17 to four manufacturers: J Well; YGT Investment and 7 Daze; Liquid Filling Solutions; and SRV. This latest round of inquiries follows a similar request for information letter sent April 24 to JUUL Labs.

The agency is seeking information including, but not limited to, “documents related to product marketing, documents related to research on product design (as it may relate to the appeal or addictive potential for youth, youth-related adverse experiences), and consumer complaints associated with products,” the agency said in a statement.

The May 17 letters note that the four companies manufacture products similar to JUUL’s product offering, sharing similar characteristics, “including e-liquids that contain nicotine salts with corresponding high nicotine concentration, small size which makes them easily concealable, and product design features that are intuitive, even for novice [electronic nicotine delivery system] users. These attributes may relate to the appeal and addictiveness of the product, particularly for youth who may be experimenting with tobacco products.”

The action is the latest in the agency’s effort to combat nicotine addiction. In March, the agency issues an advanced notice of proposed rule making seeking information on the role flavoring plays in youth tobacco consumption.

Recommended Reading

Interferon-gamma release assay trumps tuberculin skin test in school-aged children
MDedge Family Medicine
ED visits higher among pediatric asthma patients with comorbid depression, anxiety
MDedge Family Medicine
When and how to suspect asthma misdiagnosis
MDedge Family Medicine
In PAH trials, clinical worsening risk rose with time
MDedge Family Medicine
Ivacaftor reduced hospitalizations in CF
MDedge Family Medicine
Patients with CF at increased risk for GI cancers
MDedge Family Medicine
Parents smoke less tobacco, more cannabis at home
MDedge Family Medicine
E-cigarette usage has changed
MDedge Family Medicine
Methotrexate-induced pulmonary fibrosis risk examined in 10-year study
MDedge Family Medicine
As-needed budesonide-formoterol prevented exacerbations in mild asthma
MDedge Family Medicine